George Nijmeh, MD
Cardiovascular Disease · Winfield, ILNPI 1366645046
Payments from drug & device makers
Across 343 payments — averaging $1384.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$337K
- Novartis$108K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$23K
- Boehringer Ingelheim$3K
- AstraZeneca$481
- Johnson & Johnson$480
- plus $3K from 19 others
Across 2 payments — averaging $22,053 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$44K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 4 | $336,676 |
| Novartis | 51 | $108,184 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 24 | $22,549 |
| Boehringer Ingelheim | 14 | $3,250 |
| AstraZeneca | 24 | $481 |
| Johnson & Johnson | 34 | $480 |
| Pfizer | 57 | $458 |
| E.r. Squibb & Sons, L.L.C. | 53 | $434 |
| Amgen | 23 | $386 |
| Heartflow, Inc. | 5 | $356 |
| Abbott | 4 | $356 |
| Boston Scientific | 10 | $317 |
| Merck | 12 | $259 |
| Medtronic | 2 | $237 |
| Scpharmaceuticals Inc. | 5 | $103 |
| Chiesi USA, Inc. | 5 | $88 |
| Edwards Lifesciences | 1 | $73 |
| Kestra Medical Technology Services, Inc. | 3 | $64 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $50 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $43 |
| Bayer | 2 | $42 |
| Sanofi-aventis U.S. LLC | 2 | $40 |
| Esperion Therapeutics, Inc. | 2 | $30 |
| GSK | 1 | $25 |
| Amarin Pharma, Inc. | 1 | $15 |
How this compares
$474,996 in reported general payments places this provider in the 95th percentile of 932 cardiovascular disease providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Winfield
- Benjamin LumicaoChicago$3.7M
- Paul CremerChicago$2.9M
- Lokesh ChandraHazel Crest$2.7M
- Steven LupovitchArlington Heights$2.6M
- Nitasha SarswatChicago$2M
- Alan BrownNaperville$1.5M
- Alexander AdlerPeoria$1.5M
- Clifford KavinskyMaywood$1.4M
- Sanjiv ShahChicago$1.2M
- Sandeep NathanChicago$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.